US Stock MarketDetailed Quotes

Nuvectis Pharma (NVCT)

Watchlist
  • 8.900
  • +0.110+1.25%
Close Apr 24 16:00 ET
  • 8.900
  • 0.0000.00%
Post 16:04 ET
235.78MMarket Cap-6.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nuvectis Pharma (NVCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
38.93%27.57M
18.11%7.62M
78.80%7.79M
42.04%6.6M
26.66%5.57M
-13.32%19.85M
-6.07%6.45M
-29.21%4.36M
-19.56%4.64M
7.19%4.4M
Selling and administrative expenses
35.96%9.42M
29.60%2.53M
31.17%2.02M
75.41%2.98M
8.76%1.89M
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
0.12%1.74M
-General and administrative expense
35.96%9.42M
29.60%2.53M
31.17%2.02M
75.41%2.98M
8.76%1.89M
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
0.12%1.74M
Research and development costs
40.52%18.15M
13.12%5.09M
104.82%5.77M
22.77%3.61M
38.35%3.68M
-16.01%12.92M
5.42%4.5M
-37.16%2.82M
-30.95%2.94M
12.38%2.66M
Operating profit
-38.93%-27.57M
-18.11%-7.62M
-78.80%-7.79M
-42.04%-6.6M
-26.66%-5.57M
13.32%-19.85M
6.07%-6.45M
29.21%-4.36M
19.56%-4.64M
-7.19%-4.4M
Net non-operating interest income expense
33.65%1.13M
50.75%303K
61.17%332K
21.40%261K
4.89%236K
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
332.69%225K
Non-operating interest income
33.65%1.13M
50.75%303K
61.17%332K
21.40%261K
4.89%236K
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
332.69%225K
Other net income (expense)
Income before tax
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
Income tax
Net income
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
Net income continuous Operations
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
Minority interest income
Net income attributable to the parent company
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
Preferred stock dividends
Other preferred stock dividends
2.43M
0
2.43M
0
0
0
Net income attributable to common stockholders
-51.95%-28.87M
-17.06%-7.31M
-138.17%-9.89M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
Basic earnings per share
-18.92%-1.32
13.89%-0.31
-83.33%-0.44
-15.38%-0.3
-8.00%-0.27
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
7.41%-0.25
Diluted earnings per share
-18.92%-1.32
13.89%-0.31
-83.33%-0.44
-15.38%-0.3
-8.00%-0.27
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
7.41%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 38.93%27.57M18.11%7.62M78.80%7.79M42.04%6.6M26.66%5.57M-13.32%19.85M-6.07%6.45M-29.21%4.36M-19.56%4.64M7.19%4.4M
Selling and administrative expenses 35.96%9.42M29.60%2.53M31.17%2.02M75.41%2.98M8.76%1.89M-7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M0.12%1.74M
-General and administrative expense 35.96%9.42M29.60%2.53M31.17%2.02M75.41%2.98M8.76%1.89M-7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M0.12%1.74M
Research and development costs 40.52%18.15M13.12%5.09M104.82%5.77M22.77%3.61M38.35%3.68M-16.01%12.92M5.42%4.5M-37.16%2.82M-30.95%2.94M12.38%2.66M
Operating profit -38.93%-27.57M-18.11%-7.62M-78.80%-7.79M-42.04%-6.6M-26.66%-5.57M13.32%-19.85M6.07%-6.45M29.21%-4.36M19.56%-4.64M-7.19%-4.4M
Net non-operating interest income expense 33.65%1.13M50.75%303K61.17%332K21.40%261K4.89%236K32.97%847K-17.62%201K-25.63%206K235.94%215K332.69%225K
Non-operating interest income 33.65%1.13M50.75%303K61.17%332K21.40%261K4.89%236K32.97%847K-17.62%201K-25.63%206K235.94%215K332.69%225K
Other net income (expense)
Income before tax -39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M
Income tax
Net income -39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M
Net income continuous Operations -39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M
Minority interest income
Net income attributable to the parent company -39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M
Preferred stock dividends
Other preferred stock dividends 2.43M02.43M000
Net income attributable to common stockholders -51.95%-28.87M-17.06%-7.31M-138.17%-9.89M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M
Basic earnings per share -18.92%-1.3213.89%-0.31-83.33%-0.44-15.38%-0.3-8.00%-0.2722.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.267.41%-0.25
Diluted earnings per share -18.92%-1.3213.89%-0.31-83.33%-0.44-15.38%-0.3-8.00%-0.2722.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.267.41%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -